Rapid Diagnostek Receives $4,635,000 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2ed3fef3-0875-4f07-a2f2-adb49c4d28b5&Preview=1 -
Date
6/6/2012 -
Company Name
Rapid Diagnostek -
Mailing Address
1301 Gateway Circle Hudson, WI 54016 -
Company Description
Rapid Diagnostek is utilizing proprietary technology to develop a new generation of in vitro diagnostic tests through the use of our patented RFPS (radio frequency phase shift) detection technology and our disposable IntelliProbe Immunosensor (IPI). We are making this elegantly simple technology platform available for licensing by companies in the human health, veterinary medical, food safety, and environmental testing markets. Our technology is useful for performing tests that are sensitive and specific, easy to use and interpret, provide results in minutes, are cost effective, and require no added reagents. -
Website
http://www.rapiddiagnostek.com -
Transaction Type
Venture Equity -
Transaction Amount
$4,635,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
